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Abstract 
The genome of the severe acute respiratory syndrome coronavirus encodes for eight 
accessory viral proteins with no known homologues in other coronaviruses. One of these 
is the 3b protein, which is encoded by the second open reading frame in subgenomic RNA 
3 and contains 154 amino acids. Here, a detailed time-course study was performed to 
compare the apoptosis and necrosis profiles induced by full-length 3b, a 3b mutant that 
was deleted by 30 amino acids from the C terminus (3b∆124-154) and the classical 
apoptosis inducer, Bax. Our results showed that Vero E6 cells transfected with a construct 
for expressing 3b underwent necrosis as early as 6 h after transfection and underwent 
simultaneous necrosis and apoptosis at later time-points. At all the time-points analysed, 
the apoptosis induced by the expression of 3b was less than the level induced by Bax but 
the level of necrosis was comparable. The 3b∆124-154 mutant behaves in a similar 
manner indicating that the localization of the 3b protein does not seems to be important 
for the cell-death pathways since full-length 3b is localized predominantly to the 
nucleolus, while the mutant is found to be concentrated in the peri-nuclear regions. To 
our knowledge, this is the first report of the induction of necrosis by a SARS-CoV protein. 
 
1. Introduction 
Severe acute respiratory syndrome (SARS) originated in early November 2002 in 
Guangdong province, People’s Republic of China. The disease soon spread worldwide 
infecting more than 8000 people, with more than 700 fatalities (World Health 
Organization, http://www.who.int/csr/sars/country/en/). The causative agent of SARS 
was identified as a novel coronavirus, now known as SARS-CoV (for reviews, see Berger et 
al., 2004; Christian et al., 2004; Peiris et al., 2004). SARS-CoV contains a RNAgenome 
of∼30 kilobases, which encodes for up to 14 potential open reading frames (ORFs) (Marra 
et al., 2003; Rota et al., 2003). In addition to the replicase polyproteins (pp1a and pp1ab) 
and structural proteins, spike, membrane, nucleocapsid and envelope, which are common 
to all members of the genus coronavirus, the SARS-CoV genome also encodes eight 
putative proteins with no significant sequence homology to viral proteins of other known 
coronaviruses (i.e.ORF3a, 3b, 6, 7a, 7b, 8a, 8b and 9b) (Marra et al., 2003; Snijder et al., 
2003; Tan et al., 2005a). It has not yet been established which of the SARS-CoV accessory 
proteins are essential for viral replication and/or for viral–host interactions. However, the 
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over-expression of some of these SARS-CoV accessory proteins (3a, 7a, 3b) have been 
shown to induce apoptosis in cell culture (Law et al., 2005; Tan et al., 2004a; Yuan et al., 
2005a), suggesting that they may play a role in viral pathogenesis. 
 
The second largest subgenomic RNA of SARS-CoV (sgRNA3) contains two ORFs, 3a and 
3b. The 3a protein has been characterized to a great extent and has been shown to be 
expressed in infected cells both in vitro and in vivo (Chan et al., 2005; Ito et al., 2005; 
Law et al., 2005; Tan et al., 2004c; Yu et al., 2004; Zeng et al., 2004). It is a novel 
coronavirus structural protein (Ito et al., 2005; Shen et al., 2005) and can up-regulate the 
expression of fibrinogen in lung cells (Tan et al., 2005b). The 3b protein is likely to be 
expressed via an internal ribosomal entry mechanism since its translation initiation 
codon is not the first AUG in sgRNA3 (Snijder et al., 2003). It has been detected in SARS-
CoV infected cells (Chan et al., 2005), and anti-3b antibody has been detected in a SARS 
patient’s serum (Guo et al., 2004), suggesting that it is expressed in vivo. The 3b protein 
contains two predicted nuclear localization signals and has been shown to localize to the 
nucleolus of transfected cells in the absence of any other SARS-CoV proteins (Yuan et al., 
2005b). In addition, the over-expression of 3b causes G0/G1 arrest and induces apoptosis 
(Yuan et al., 2005a). 
 
In this study, we determined the mechanism of cell-death induced by the over-expression 
of full-length 3b or a 3b mutant that lacks the C-terminal 30 amino acids (3b∆124-154). 
By following the time-course of expression, we compared the apoptosis and necrosis 
profiles induced by full-length 3b, 3b∆124-154 mutant and the classical apoptosis inducer, 
Bax. Terminal deoxynucleotidyl transferase mediated dUTP nick-end-labeling (TUNEL) 
assays and subcellular fractionation were performed to further delineate the cell-death 
pathways. 
 
2. Methods 
2.1. Materials 
All reagents used in this study were purchased from Sigma (St. Louis, MO, USA) unless 
otherwise stated. Vero E6 (African green monkey kidney epithelial) cells were grown in 
Dulbecco’s modified Eagle medium containing 0.1 mg/ml streptomycin and 100U 
penicillin and 5% FBS (HyClone, UT, USA). Cells were cultured at 37 ◦C in an incubator 
supplied with 5% CO2. 
 
2.2. Construction of plasmids 
To clone the 3b gene into pXJ40HA mammalian expression vector, the 3b ORF was 
amplified using 3b-forward (5’-CCGCTCGAGGCCACCATGATGCCAA-3’) and 3b-reverse 
(5’-ATAAGAATGCGGCCGCTTAACGTACCTGTTTC-3’) primers. cDNA prepared from 
SARS-CoV infected cells was used as template as previously described (Tan et al., 2004b). 
The PCR product was digested with restriction enzymes (XhoI and NotI) and ligated to 
linearized pXJ40HA digested with the same restriction enzymes. The pXJ40HA-3b_124-
154 plasmid for expressing a 3b mutant without the C-terminal 30 amino acids was made 
in a similar manner using the 3b-forward primer and 3b∆124-154-reverse (5’-
ATAAGAATGCGGCCGCTTACATCATAAATTG-3’) primer. All plasmid sequences were 
confirmed by sequence analysis. 
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2.3. Transfection and CaspACE fluorometric assay 
Vero E6 cells were plated on 6 cm tissue culture dishes and allowed to grow to 70% 
confluence before the cells were transfected with 3µg of pXJ40HA-3b or pXJ40HA-
3b_124-154 using Lipofectamine reagent (Invitrogen, Carlsbad, CA), according to 
manufacturer’s protocol. To reduce the rate of apoptosis induced by the potent apoptosis 
inducer, Bax, 1µg of pXJ40HA-Bax was used with 2µg of empty vector instead. For mock 
transfection, no DNA was used but the cells were incubated with the same amount of 
Lipofectamine reagent. Each plate of cells was harvested at various time-points, i.e. 6, 12, 
18 and 48 h, after transfection. The cells were then washed with phosphate-buffered 
saline (PBS) and resuspended in 110 _l of lysis buffer (50mM Tris–HCl (pH 8.0), 150mM 
NaCl, 0.5% NP40, 0.5% deoxycholic acid, 0.005% SDS), containing 1mM PMSF. Half of 
the suspensionwas then subjected to three rounds of freeze-thawcycles and then 
centrifuged to remove cell debris. The total protein concentration of the lysate was 
determined by using Coomassie Plus reagent from Pierce (Rockford, IL). The amount of 
caspase-3 activity in 10 _g of total protein was then determined by using the CaspACE 
fluorometric assay system from Promega Corporation (Madison, WI). All experiments 
were performed in duplicates. Laemmli’s sodium dodecyl sulphate buffer (SDS buffer) 
was added to the other half of the cell suspension. As the 3b protein tends to form large 
aggregates when boiled, the SDS–cell mixture was incubated at 50 ◦C for 15 min 
beforeWestern blot analysis. For HA-Bax, the SDS–cell mixture was heated at 100 ◦C for 
10 min.  
 
2.4. Western blot analysis 
For Western blot analysis, cell lysates were separated on SDS-PAGE and transferred onto 
Hybond-C membranes (Amersham Pharmacia Biotech, Uppsala, Sweden). The 
membranes were then blocked with 5% non-fat milk for 30 min and probed with primary 
antibodies (anti-HA monoclonal antibody (1:1000; Roche Molecular Biochemicals, 
Indianapolis, IN) or anti-poly(ADP-ribose) polymerase (PARP) polyclonal antibody 
(1:1000; Cell Signaling Technology, Inc., Beverly, MA) or antiactin monoclonal antibody 
(1:3000; Sigma)) with rolling at 4 ◦C overnight. After three washes (15 min each) 
withPBScontaining 0.05% Tween 20 (PBST), the membranes were incubated with goat 
anti-rabbit or anti-mouse horse-radish peroxidase (HRP)-conjugated secondary 
antibodies (1:2000, Pierce) at room temperature, with rolling for 1 h. The membranes 
were then washed with PBST three times for 15 min each, and visualized using an 
enhanced chemiluminescence method (Supersignal West Pico, Pierce). 
 
2.5. CytoTox-ONE homogenous membrane integrity assay 
Vero E6 cells were plated in 6 cm tissue culture dish and transfected as described above. 
At each time-point, 110µl of the culture medium were transferred to a 96-well plate and 
the amount of lactate dehydrogenase (LDH) released from damaged necrotic cells was 
determined using the CytoTox-ONE homogenous membrane integrity assay (Promega) 
according to manufacturer’s protocol. All experiments were performed in duplicates. 
 
2.6. DeadENd fluorometric TUNEL and immunofluorescence experiments 
Vero E6 cells were seeded on cover slips and transfected as described above. Cells were 
analysed for DNA fragmentation by using the DeadENd fluorometric TUNEL system 
(Promega) according to manufacturer’s protocol. Cells treated with DNase I (Roche) 
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served as a positive control. The cell nuclei were counterstained with 1µg/ml propidium 
iodide. For immunofluorescence experiments, the cover slips were fixed in methanol for 5 
min at −20 ◦C, after which the cover slips were completely air-dried. Cells were blocked 
with PBS with 1% bovine serum albumin for 30 min, and then incubated with anti-HA 
antibody at a dilution of 1:200 for 1 h. Following washing, cells were incubated with the 
fluorescein isothicyanate (FITC)-conjugated goat anti-mouse secondary antibody (1:100; 
Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h. 
 
2.7. Subcellular fractionation 
Vero E6 cells were plated in 10 cm tissue culture dish and transfected as described above. 
In this case, 6µg of pXJ40HA-3b or pXJ40HA-3b∆124-154 was used. Fractionation was 
then performed to separate the cytoplasmic, nuclear and membrane components of the 
cell. The method used was adapted from Spector et al. (1988) with some modifications 
and is described below. At different time-points, the cells were harvested and washed 
twice with cold PBS and resuspended in 200µl hypotonic buffer (10mM Tris–HCl (pH 
7.5), 2mM MgCl2, 0.5mM PMSF) and left in ice-water for 5 min. 0.25% Triton-X 100 was 
then added and the cells were sheared by passing through a 21G needle thrice. The cells 
was then left in ice-water for 5 min and spun at 3000 rpm at 4 ◦C for 5 min (step A). The 
supernatant was transferred to a clean tube and spun again at 14,000 rpm at 4 ◦C for 20 
min (step B) and the supernatant was collected (cytoplasmic fraction). The pellet after 
step B (membrane fraction) was resuspended in 200µl of lysis buffer with DNase I (1 
µl/ml), and left at room temperature for 15 min to degrade the cellular DNA. To wash the 
pellet from step A (nuclear fraction), it was resuspended in 0.5 ml ice-cold hypotonic 
buffer and spun at 3000 rpm at 4 ◦C for 5 min and the supernatant was discarded. After 
two washes, the pellet was resuspended in 200 µl of lysis buffer with DNase I. Finally, 50 
µl of 5XSDS buffer was added to each of the fractions and the mixtures were vortexed and 
left at room temperature for 15 min, followed by incubation at 50 ◦C for 15 min. Then, 
20µl of each fraction was subjected to Western blot analysis as described above. 
 
3. Results and discussion  
Recently, Yuan and co-workers showed that the overexpression of SARS-CoV 3b in COS-
7, Vero and 293 induces cell-cycle arrest but they could only observed significant 
apoptosis in COS-7 cells (Yuan et al., 2005a). Here, a time-course study was performed to 
characterize the profile of cell-death induced by the over-expression of 3b in Vero E6 cells 
in order to understand the role of 3b during the viral replication cycle in Vero E6 cells. In 
addition, the cell-death profiles of full-length 3b and a deletion mutant, 3b∆124-154, 
which lacks the C-terminal 30 amino acids, were compared to that of Bax, a classical 
apoptosis inducer. The general opinion is that cell death can either be as a result of 
necrosis, defined as a passive and non-physiological type of death caused by accidental 
and acute damage to the cell, or the consequence of apoptosis, defined as an active and 
genetically regulated process of cell suicide by which an organism eliminates senescent, 
abnormal and potentially harmful cells (for reviews, see Ameison, 2002; Guimar˜aes and 
Linden, 2004; Los et al., 2002; Nelson and White, 2004; Zhivotosky, 2004). These two 
forms of cell death are distinguishable by their morphological and biochemical effects on 
the cell. However, recent studies have shown that necrosis is also highly regulated and a 
fine regulatory line exists between necrosis and apoptosis as many anti-apoptotic 
mechanisms are also effective against necrosis (for reviews, see Proskuryakov et al., 2003; 
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Syntichaki and Tavernarakis, 2002, 2003). For the sake of simplicity, we shall use the 
term necrosis to refer to the form of cell death not involving the apoptotic early steps, and 
secondary necrosis to describe the subsequent degradative changes that apoptotic cells 
undergo at the late stages of apoptosis.  
 
Vero E6 cells were analysed at 6, 12, 18 and 48 h after transfection with plasmids for 
expressing HA-3b, HA-3b∆124-154 and HA-Bax to determine the degree of apoptosis and 
necrosis. The expression of the proteins were detected using anti-HA monoclonal 
antibody (Fig. 1A and B). As shown in Fig. 1C, the over-expression of 3b and 3b∆124-154 
resulted in a slight increase in caspase 3 activity, which is a hallmark of apoptosis, at 6 h 
post-transfection. The level of caspase 3 activity continued to increase until 12 h after 
transfection but showed gradual decrease at 18 and 48 h after transfection. Consistently, 
the expression of 3b and 3b∆124-154 also resulted in cleavage of endogenous PARP, 
which is a substrate of activated caspase-3 (Fig. 1A) from 12 h onwards. This profile 
mirrored that of Bax, except that the level of caspase 3 activities for 3b and 3b∆124-154 
were lower than for Bax at all the time-points and that Bax already showed high level of 
caspase 3 activities and PARP cleavage at 6 h (Fig. 1B and C). These results are somewhat 
different from the report byYuan et al. (2005a) where the over-expression of 3b did not 
induce apoptosis in Vero cells, and furthermore, showed that the C-terminal 30 amino-
acids of 3b are not important for apoptosis induction. The discrepancy may be due to 
differences in transfection efficiency and/or sensitivity of the assays used. 
 
In all cases, we noted that a decease in caspase 3 activity after 18 h of transfection, 
suggesting that the apoptotic cells were going into secondary necrosis. A key marker of a 
cell undergoing necrosis is the loss of their membrane integrity and the release of their 
cytoplasmic contents into the surrounding culture. Thus, the CytoTox-ONE assay 
(Promega), which measures the release of lactate dehydrogenase (LDH) from cells with 
damaged membranes, was used to quantify the degree of necrosis at different time-points. 
For the over-expression of 3b and 3b∆124-154, significant amounts of LDH were released 
as early as 6 h post-transfection as compared to the low level of LDH released from mock 
transfected cells (Fig. 1D). The levels of LDH then increased gradually up to 12 h. 
Interestingly, the level of LDH released from cells expressing Bax was about the same as 
for 3b and 3b∆124-154 at 6 h, 12 h and 18 h, even though the level of apoptosis caused by 
the over-expression of Bax was consistently higher that caused by 3b or 3b∆124-154. The 
gradual increase in the level of necrosis in the Bax expressing cells was expected as 
apoptotic cells would undergo secondary necrosis at the late stages (Ameison, 2002; 
Guimar˜aes and Linden, 2004; Los et al., 2002; Nelson and White, 2004; Zhivotosky, 
2004). 
 
These results showed that the expression of 3b induces necrosis as early as 6 h post-
transfection when the level of apoptosis was very much lower than that for Bax. Again, the 
C-terminal 30 amino acids of 3b do not have any effects on its ability to induce necrosis. 
At time-points greater than 6 h post-infection, it appears that both necrosis and apoptosis 
(and secondary necrosis) were occurring simultaneously in cell over-expressing 3b or 
3b∆124-154. At 48 h post-transfection, there was a surge of LDH release from cells 
expressing 3b or 3b∆124-154 or Bax or even the mock transfected cells, indicating that by 
this time, the Lipofectamine reagent used for transfection had some unspecific cytotoxic 
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effects or the cells were over-grown (Fig. 1D). Thus, subsequent experiments were only 
performed up to 18 h post-transfection. 
 
 
 
TUNEL assays were performed to examine whether the 3b and 3b∆124-154 could induce 
DNA fragmentation, a common phenomenon of apoptosis. At all the time-points, DNA 
fragmentations were observed in 3b- and 3b∆124-154-transfected Vero E6 cells. A 
representative set of data for 18 h post-transfection is shown in Fig. 2 (first and second 
rows). DNA fragmentations in cells expressing 3b or 3b_124-154 (note that the typical 
transfection efficiency achieved in this study was about 30%) were indicated by FITC 
positive signals while nuclei of all the cells in the field were counterstained using 
propidium iodide. DNA fragmentation was also be detected in the cells transfected with 
Bax (Fig. 2, third row) and in cells that were treated with DNase I (positive control) (Fig. 
2, fifth row). Under the same exposure conditions, there was no sign of DNA 
fragmentation in the mock transfected cells (Fig. 2, fourth row). Next, the subcellular 
localization of 3b and 3b∆124-154 was examined by subcellular fractionation studies 
performed at 6, 12 and 18 h post-transfection. Consistent with previous report (Yuan et 
al., 2005b), the full-length 3b protein was found to partition solely in the nuclear fraction 
at all the time-points (Fig. 3A). The 3b deletion mutant, 3b∆124-154, was initially found 
in the cytoplasmic fraction (6 h post-transfection), but with time, could be more 
efficiently detected in the membrane and nuclear fractions (Fig. 3B). As a control for the 
fractionation method, endogenous actin was detected in the cytoplasmic fractions for all 
transfections. 
 
Next, indirect immunofluorescence was also performed at 18 h post-transfection to 
compare the subcellular localization of 3b and 3b∆124-154 in Vero E6 cells (Fig. 3C). 
Consistent with the fractionation experiments above, indirect immunofluorescence 
revealed that the 3b protein was localized primarily in the nucleolus of transfected cells 
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and somewhat less around the nucleus. The latter is likely to be the nuclear membrane as 
3b was isolated in the nuclear fraction (Fig. 3A). In contrast, 3b∆124-154 was localized to 
the perinuclear regions, while Bax was diffusely localized in the cytoplasm. Since the 
fractionation experiments showed that 3b∆124-154 was found predominantly in the 
membrane and nuclear fractions at late time-points (Fig. 3B), it is likely that the intense 
staining around the nucleus represents both perinuclear membranous organelles, like the 
endoplasmic reticulum or Golgi apparatus, as well as nuclear membrane, with the latter 
being partitioned into the nuclear fraction. 
 
 
 
Amino acids 134–154 of 3b have been previously shown to contain a nucleolar localization 
signal (Yuan et al., 2005b). Consistently, we observed that unlike full-length 3b, the 
3b∆124-154 mutant was not efficiently transported to the nucleolus. In summary, we 
demonstrated that Vero E6 cells transfected with a construct for expressing 3b underwent 
necrosis as early as 6 h after transfection and underwent simultaneous necrosis and 
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apoptosis at later time-points. At all the time-points analysed, the apoptosis induced by 
the expression of 3b was less than the level induced by Bax but the level of necrosis was 
comparable to that induced by over-expression of Bax. Hence, it is clear that 3b induces 
necrosis at the early time-point and apoptosis (and secondary necrosis) at late time-
points. 
 
 
The deletion mutant 3b∆124-154 behaves in a similar manner indicating that the 
localization of 3b does not seems to be important for the cell death pathways since full-
length 3b is localized predominantly to the nucleolus, while the mutant is found to be 
concentrated in the peri-nuclear regions. Recently, Yount et al. (2005) showed by reverse 
genetics experiment that recombinant virus containing a deletion of the ORF3a, which 
resulted in the movement of ORF3b to the 5’ end of the mRNA and an increase in the level 
of 3b expression, has a lower viral yield than wild-type virus. On the other hand, if both 3a 
and 3b are deleted, there is no significant difference from wild-type virus, thus suggesting 
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that the over-expression of 3b may have a deleterious effect on viral yield (Yount et al., 
2005). It remains to be determined if the necrotic effect on the cells caused by the over-
expression of 3b could play a part in reducing the viral titre. Interestingly, Hussain et al. 
(2005) reported that the 3b protein can also be expressed from an independent 
subgenomic RNA but this is a rare event. Given the findings that over-expression of 3b 
can cause rapid necrosis and may reduce virus titer in cell culture systems, it is crucial to 
further understand how the expression level of 3b is modulated during SARS-CoV 
infection. Many virus genomes encode gene products that can modulate apoptosis and the 
regulation of apoptosis in infected the host is an important determinant in the struggle 
between virus and host for survival (for review, see Barber, 2001; Benedict et al., 2002; 
Boya et al., 2001; Hay and Kannourakis, 2002; Mori et al., 2004; Thomson, 2001). 
However, the role of necrosis in viral infection is less clear, partly because the necrosis 
process is less well-studied. Nevertheless, to date, necrosis has been shown to play an 
important role during viral infection by at least four viruses (An et al., 2000; Espinoza et 
al., 2005; Miller and Fox, 2004; Ran et al., 1999). Whether or not necrosis is important 
for SARS-CoV infection remains to be determined. Interestingly, necrosis was observed in 
different tissues obtained from SARSCoV infected patients (Chong et al., 2004; Ding et 
al., 2003; Lang et al., 2003; Xu et al., 2005) and many SARS-CoV infected laboratory 
animals, including cynomologus macaques (Fouchier et al., 2003; Kuiken et al., 2003), 
rhesus macaques (Qin et al., 2005), common marmosets (Greenough et al., 2005), golden 
syrian hamster (Roberts et al., 2005b) and aged BALB/c mice (Roberts et al., 2005a). 
However, necrosis was not observed in SARS-CoV infected Vero E6 cells (Yan et al., 
2004), suggesting that the level of 3b may not be sufficient to induce necrosis in Vero E6 
cells. However, we cannot rule out that the expression of 3b may be higher in SARS 
patients and/or SARS-CoV infected animals than in SARS-CoV infected cell culture. 
Further studies using animal models will be necessary to give a more definitive answer. 
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